Blevins Brothers Fortnite Charity Event at Michigan Stadium Raises Over $90,000 for Cancer Research

Author | Sam Page

Ninja and BeardedBlevins stand on the field at Michigan Stadium.

The Blevins Brothers—Ninja and BeardedBlevins—raised $93,125 for the University of Michigan Health Rogel Cancer Center by playing Fortnite live from Michigan Stadium.

Michigan natives and world-famous video game streamers, the brothers broadcast on Twitch for over five hours, garnering hundreds of thousands of views and 650 donations. 

“I want to thank everyone who helped put this incredible event together, along with the companies and members of our communities who generously donated,” said Tyler Blevins, better known as Ninja.

“It’s amazing to raise nearly $100,000 for cancer research in five hours, but it’s even better to know that you’re giving it to the right place doing the right work.”

During the visit, Ninja and BeardedBlevins streamed with a rotating cast of special U-M guests, including Wolverine quarterbacks Davis Warren and Alex Orji, San Francisco 49ers kicker Jake Moody, Olympic bronze medalist Paul Juda, and the U-M men’s basketball team’s Danny Wolf. 

The donated funds, which will be used to support the Rogel Cancer Center’s innovative research, were made possible by matching sponsors Alro Steel, Domino’s, and Michigan Mudbowl—and the support of in-kind sponsors PowerGPU, Nvidia, and Team Ninja. Amazon sponsored the guest chair.

The streamers also toured labs within the Rogel Center, spoke with researchers and heard stories about how the work they were supporting leads to the prevention, diagnosis and treatment of cancer.

“It was a great pleasure hosting a lab tour to show Ninja and BeardedBlevins how our research team studies skin cancer in the Rogel Cancer Center,” said Andrzej Dlugosz, M.D., the center’s Associate Director for Basic Science Research.

“The goal of our work is to understand the cause of these cancers and discover more effective ways to treat or prevent them.”

As top-ranked health care providers in the nation, Michigan Medicine and the Rogel Cancer Center are leading efforts to generate new knowledge and advance research to transform cancer prevention and treatment. 

“Working with the University of Michigan Health Rogel Cancer Center has been an absolute honor,” said Jonathan Blevins, aka BeardedBlevins.

“I was blown away by all of the life-changing work that everyone in that building is doing. They shared some miraculous stories with us, and I will never forget those few hours. I can't wait to continue to support the work they are doing. Go Blue!”


More Articles About:

Rogel Cancer Center

Featured News & Stories

Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Group of men smiling in a field
News Release

How have diagnostic and treatment decisions for prostate cancer changed in recent years?

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis by University of Michigan Rogel Cancer Center researchers, indicates a shift toward surveillance in response to concerns of overdiagnosis and overtreatment that have hindered screening in the recent past.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
Three people stand arm in arm with backs to camera studying a wall of family mementos
Health Lab

Online resources and coaching helped people seek genetic testing for cancer

New study from researchers at the University of Michigan Rogel Cancer Center showed an online resource and phone-based coaching both helped increase rates of genetic testing.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
man smiling with glasses in booth
Health Lab

Exceptional response to immunotherapy gives patient with liver cancer more milestones to celebrate

U-M Health Rogel Cancer Center used single-dose immunotherapy and transplant oncology to treat advanced hepatocellular carcinoma in a 69-year-old patient.